secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001140361-24-025326
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q1 revenue up 53% to $5.8M; operating loss narrows to $1.1M; reaffirms FY 2024 growth guidance of 50%
--------------------------------------------------------------------------------

- Revenue $5.8M (+53% YoY); gross margin 73% (+600bps); UltraMist consumables revenue $4.1M (+64%).
- Operating loss $1.1M vs $2.0M in Q1 2023; net loss $4.5M includes $3.9M non-cash derivative charge.
- Adjusted EBITDA loss improved to $59K from $1.8M loss YoY.
- Guidance: Q2 2024 revenue growth 45-55% YoY; FY 2024 revenue growth of 50% reiterated.
- Sold 43 UltraMist systems in Q1 (up from 28 in Q1 2023, down from 79 in Q4 2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/0001140361-24-025326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/ef20028815_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-025326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer